Notícias

General Motors (GM) raised its 2026 outlook by $500 million, thanks in part to better margins and lower tariffs. Morning Brief host Julie Hyman discusses more with Yahoo Finance Breaking Business News Reporter Jake Conley and Payne Capital Management president Ryan Payne.

Alphabet faces heightened scrutiny from investors as a delay in the launch of a model key to its AI ‌ambitions adds to worries over the payoff from massive data-center spending, months after raising ‌expectations with a blockbuster quarter for cloud sales. The Google parent — set to report second-quarter results on Wednesday — has delayed from ​June the launch of its next flagship model, Gemini 3.5 Pro, built especially to catch up with rivals in the lucrative market for AI coding tools and agentic AI tasks. "While Google is missing the boat on AI coding and that's a very real growing concern ... Google's strategy is ⁠all about the ecosystem," said Dave Wagner, portfolio manager at Aptus Capital Advisors.

Tesla on Tuesday expanded its robotaxi service to Orlando and Tampa, as ‌the electric-vehicle maker races to prove that ‌it can scale its autonomous ride-hailing business beyond its initial ​launch markets. The move comes a day before Tesla reports second-quarter earnings, with Wall Street closely watching the progress on robotaxis, which underpin much of the company's ‌valuation as CEO ⁠Elon Musk shifts focus toward artificial intelligence, autonomous driving and humanoid robots. Tesla launched its ⁠robotaxi service in Austin in June last year and expanded to Dallas and Houston earlier this year ​and ​Miami this month.

Constellation Energy is set to report its second-quarter results in August, and analysts expect a double-digit earnings growth.

The oilfield services company posted net income of $472 million in the second quarter, up from $204 million in the prior quarter

3M Company will release earnings for its second quarter before the opening bell on Tuesday, July 21. Analysts expect the company to report quarterly earnings of $2.25 per share, up from $2.16 per share in the year-ago period. The consensus...

Earnings optimism supports pre-market gainsU. S.

By Sarah Young FARNBOROUGH, England, July 21 (Reuters) - Britain's Rolls-Royce needs a decision from the UK government soon on whether it will provide a subsidy to help the engineering company develop

Investors have long priced in oil shocks and inflation from Middle East conflicts, but the Iran war is targeting something far more unfamiliar: the physical data centers powering the global cloud economy, and Big Tech is already absorbing the damage.

Bank of ‌America said on Tuesday ‌it has enhanced its ​AI-powered EricaAssist tool, which would help more than 18,000 customer service ‌representatives resolve ⁠client needs faster by delivering real-time ⁠guidance during conversations. The new generative AI ​capabilities deliver ​contextual ​guidance in under ‌three seconds,, the bank said in a statement. The move comes as major banks are ‌ramping up how ​they incorporate ​digital ​assistants in their ‌daily operations, determining ​how ​such agents interact with human colleagues and ​clients ‌as they race to ​get ahead.

(Bloomberg) -- Kalshi Inc. is seeking approval to expand precious-metals trading on its platform with a popular type of derivative that never expires for gold, silver and platinum.Most Read from BloombergYemen’s Houthis to Impose Maritime Blockade on Saudi ArabiaChina AI Sensation Moonshot’s Gamble on Big Models Pays OffTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawMoonshot’s Kimi K3 May Be More About Memory Than ComputeUS Strikes Iran in Escalating Campaign After Troops Killed

SpaceX stock is down 45% from its highs and trades below its IPO price. Is this the contrarian buying opportunity patient investors have been waiting for?

Expedia Group will release its second-quarter earnings next month, and analysts anticipate a double-digit bottom-line growth.

Parker-Hannifin will release its fourth-quarter earnings soon, and analysts anticipate a single-digit bottom-line growth.

NEM heads into Q2 earnings with higher gold prices offset by lower production and rising costs. Margins are expected to be lower Q/Q.

The Clarity Act nears a Senate vote this week after President Trump reportedly agreed to a debated ethics provision. Crypto stocks surge.

Gilead Sciences will release its second-quarter earnings soon, and analysts anticipate a triple-digit profit dip.

Warner Bros. Discovery will release its second-quarter earnings soon, and analysts anticipate a triple-digit profit dip.

The company has a high bar for acquisitions.

Motorola Solutions is expected to announce its second-quarter results soon, and analysts predict a single-digit rise in the company’s bottom-line figure.

Northrop Grumman reported better-than-expected second-quarter earnings and raised its full-year financial guidance.

(Bloomberg) -- The biotechnology sector is stealing the US IPO market thunder from artificial intelligence-related listings, delivering standout returns as bankers line up a steady stream of summer debuts.Most Read from BloombergYemen’s Houthis to Impose Maritime Blockade on Saudi ArabiaChina AI Sensation Moonshot’s Gamble on Big Models Pays OffTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawMoonshot’s Kimi K3 May Be More About Memory Than ComputeUS Strikes Iran in Escalating Cam

Microsoft has agreed to spend billions of dollars on Mistral's computing infrastructure in Europe under a deal that will also expand distribution of the French AI startup's ‌technology through the U.S. cloud and software giant, the companies said on Tuesday. As part of the agreement, ‌Microsoft Azure customers will be able to develop software using Mistral's data centers in France, giving Microsoft more capacity in Europe and regulated industries an ​alternative to U.S.-controlled infrastructure. Mistral, meanwhile, has added its AI models called Medium 3.5 and OCR 4 to Microsoft's app builder known as Foundry.

The deal, structured as an all-stock transaction, gives Tempus control of Personalis' NeXT Personal cancer detection test

Investing.com -- The clash between pharma titans Novo Nordisk and Eli Lilly just escalated from the pharmacy counter to the courtroom. Novo Nordisk Inc. filed a lawsuit in the U.S. District Court for the District of New Jersey against Eli Lilly and Company and Lilly USA, LLC, alleging multiple violations of federal and state false advertising and unfair competition laws under the Lanham Act. The lawsuit takes aim at Lilly’s aggressive direct-to-consumer (DTC) advertising campaigns for its blockb

Microchip Technology is scheduled to post its first-quarter results soon, and analysts predict a triple-digit surge in the company’s bottom-line figure.

Two industrial giants report Q2 results on the same day, and analysts are anything but neutral between them. Before you decide which earnings announcement to watch on July 22, you need to see how these two stack up across every dimension Wall Street actually measures.

Vicor (VICR) delivered earnings and revenue surprises of +67.74% and +3.35%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Ozempic maker Novo Nordisk has filed a lawsuit against Eli Lilly, arguing it uses deceptive advertising to mislead consumers. The complaint accuses Eli Lilly of using outdated studies to promote its branded GLP-1 drugs, Mounjaro and Zepbound, as helping consumers lose significantly more weight on average than Novo Nordisk’s Ozempic and Wegovy.

Memory chip shortages continue to be a problem for most companies.